SynthesisJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review.
Synthesis in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04423042 (A Nested Interventional Cohort Study to Assess the Efficacy and Safety of Adjunctive Humanized Monoclonal Interleukin-6 Receptor Blocker Tocilizumab), which is not on this map. Cited by 82 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Nested Interventional Cohort Study to Assess the Efficacy and Safety of Adjunctive Humanized Monoclonal Interleukin-6 Receptor Blocker Tocilizumab (TCZ) Therapy to Standard of Care for the Reduction of Hyperinflammation Related Mortality in SARS-Cov2 Positive Patients
Who cites it
82 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.Reviews in medical virology · 2022Pooled it
- Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis.PloS one · 2022Pooled it
- The COVID-19 research landscape: Measuring topics and collaborations using scientific literature.Medicine · 2020Pooled it
- COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021Trial
- Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.Stem cells and development · 2020Trial
- Phytocompounds of Honey mesquite (In silico pharmacology · 2025Article
- Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis.Singapore medical journal · 2023Review
- Antiviral Therapy of COVID-19.International journal of molecular sciences · 2023Review
- The Outcome of COVID-19 Infection on Kidney Transplantation Recipients in Southern Saudi Arabia: Single-Center Experience.Transplantation proceedings · 2023Article
- Rationale for combined therapies in severe-to-critical COVID-19 patients.Frontiers in immunology · 2023Review
- Review
- Tocilizumab in severe COVID-19 - A randomized, double-blind, placebo-controlled trial.Infectious medicine · 2022Article
- Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results?Postgraduate medical journal · 2022Article
- An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).International immunopharmacology · 2022Review
- The Cause-Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic.Hematology reports · 2022Review
- Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya.International journal of general medicine · 2022Article
- Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.The Egyptian journal of internal medicine · 2022Article
- Ferritin as prognostic marker in COVID-19: the FerVid study.Postgraduate medicine · 2022Article
- Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management.Pneumonia (Nathan Qld.) · 2021Review
- Drug-based therapeutic strategies for COVID-19-infected patients and their challenges.Future microbiology · 2021Review
22 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.